Autor:	MV Lesnicheva, DY Karateyev, MV Avksentyeva, PA Vorobyev, YI Alekseyeva
Rok vydání:	2010
Předmět:	musculoskeletal diseases medicine.medical_specialty business.industry Health Policy Public Health Environmental and Occupational Health medicine.disease Dermatology immune system diseases Rheumatoid arthritis medicine Adalimumab In patient business health care economics and organizations medicine.drug
Zdroj:	Value in Health. 13:A126-A127
ISSN:	1098-3015
DOI:	10.1016/s1098-3015(10)72611-5
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c127564512c8d8b14d190d2133a8acf3 https://doi.org/10.1016/s1098-3015(10)72611-5 Zobrazit plný text záznamu Full Text from ScienceDirect Plný text